Pediatric cancer care management during the COVID-19 pandemic: a review of the literature and a single-centre real-life experience of an Italian pediatric oncology unit

References

• Chiaravalli S, Ferrari A, Sironi G, et al. A collateral effect of the COVID-19 pandemic: delayed diagnosis in pediatric solid tumors. Pediatr Blood Cancer. 2020 Oct;67(10):e28640. Epub 2020 Aug 6. PMID: 32761998; PMCID: PMC7435564. doi: 10.1002/pbc.28640
   PubMed Web of Science ®Google Scholar
• de Rojas T, Pérez-Martínez A, Cela E, et al. COVID-19 infection in children and adolescents with cancer in Madrid. Pediatr Blood Cancer. 2020 Jul;67(7):e28397. Epub 2020 May 8. PMID: 32383819; PMCID: PMC7235530. doi: 10.1002/pbc.28397.
   PubMed Web of Science ®Google Scholar
• Chou J, Thomas PG, Randolph AG. Immunology of SARS-CoV-2 infection in children. Nat Immunol. 2022 Feb;23(2):177–185. Epub 2022 Feb. doi: 10.1038/s41590-021-01123-9.
   PubMed Web of Science ®Google Scholar
• Wald ER, Schmit KM, Gusland DY. A pediatric infectious disease perspective on COVID-19. Infect Dis. 2021 May 4;72(9):1660–1666. doi: 10.1093/cid/ciaa1095
   Web of Science ®Google Scholar
• Howard-Jones AR, Burgner DP, Crawford NW, et al. COVID-19 in children. II: pathogenesis, disease spectrum and management. Paediatr Child Health. 2022 Jan;58(1):46–53. Epub 2021 Oct 25. doi: 10.1111/jpc.15811.
   Web of Science ®Google Scholar
• Dong Y, Mo X, Hu Y, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. J Emerg Med. 2020 Apr;58(4):712–713. Published online 2020 Jun 3. doi: 10.1016/j.jemermed.2020.04.006
   Google Scholar
• Bialek S, Boundy E, Bowen V, et al. Severe outcomes Among patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(12):343–346. doi: 10.15585/mmwr.mm6912e2
   PubMed Web of Science ®Google Scholar
• Lu X, Zhang L, Du H, et al. SARS-CoV-2 infection in children. N Engl J Med. 2020;382(17):1663–1665. Epub 2020 Mar 18. doi: 10.1056/NEJMc2005073
   PubMed Web of Science ®Google Scholar
• Zhao Q, Meng M, Kumar R, et al. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a systemic review and metaanalysis. Int J Infect Dis. 2020;96:131–135. Epub 2020 May 4. doi: 10.1016/j.ijid.2020.04.086.
   PubMed Web of Science ®Google Scholar
• Kainth MK, Goenka PK, Williamson KA, et al. Early experience of COVID-19 in a US children’s hospital. Pediatrics. 2020;146(4):e2020003186. Epub 2020 Jul 17. doi: 10.1542/peds.2020-003186 .
   PubMed Web of Science ®Google Scholar
• Hoang A, Chorath K, Moreira A, et al. COVID-19 in 7780 pediatric patients: a systematic review. EClinicalMedicine. 2020;24:100433. eCollection 2020 Jul. doi: 10.1016/j.eclinm.2020.100433.
   PubMedGoogle Scholar
• Millen GC, Arnold R, Cazier J-B, et al. Severity of COVID-19 in children with cancer: Report from the United Kingdom paediatric coronavirus cancer monitoring projec. Br J Cancer. 2021 Epu;124:754–759. doi: 10.1038/s41416-020-01181-0.
   PubMed Web of Science ®Google Scholar
• Haeusler GM, Ammann RA, Carlesse F, et al. SARS-CoV-2 in children with cancer or after haematopoietic stem cell transplant: an analysis of 131 patients. Eur J Cancer. 2021;159:78–86. Epub 2021 Oct 9. doi: 10.1016/j.ejca.2021.09.027.
   PubMed Web of Science ®Google Scholar
• Abi Nassif T, Fakhri G, Younis NK, et al. Cardiac manifestations in COVID-19 patients: a focus on the pediatric population. Can J Infect Dis Med Microbiol [ eCollection 2021]. 2021;2021:5518979. doi: 10.1155/2021/5518979
   PubMed Web of Science ®Google Scholar
• Chung E, Chow EJ, Wilcox NC, et al. Comparison of symptoms and RNA levels in children and adults with SARS-CoV-2 infection in the community setting. JAMA Pediatr. 2021;175(10):e212025. Epub 2021 Oct 4. doi: 10.1001/jamapediatrics.2021.2025
   PubMed Web of Science ®Google Scholar
• Cohen CA, APY L, Hachim A, et al. SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection. Nature Commun. 2021 Jul 29;12(1):4678. doi: 10.1038/s41467-021-24938-4
   PubMed Web of Science ®Google Scholar
• Garrido C, Hurst JH, Lorang CG, et al. Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents. JCI Insight. 2021 Sep 8;6(17):e150909. doi: 10.1172/jci.insight.150909
   PubMed Web of Science ®Google Scholar
• Jia R, Wang X, Liu P, et al. Mild cytokine elevation, moderate CD4(+) T cell response and abundant antibody production in children with COVID-19. Virol Sin. 2020 Dec;35(6):734–743. Epub 2020 Jul 22. doi: 10.1007/s12250-020-00265-8
   PubMed Web of Science ®Google Scholar
• Bunyavanich S, Do A, Vicencio A. Nasal gene expression of angiotensin-converting enzyme 2 in children and adults. JAMA. 2020 Jun 16;323(23):2427–2429. doi: 10.1001/jama.2020.8707
   PubMed Web of Science ®Google Scholar
• Charla Y, Kalra M, Chopra N, et al. COVID-19 vaccination in pediatric cancer patients: a high priority. Pediatr Blood Cancer. 2021 Dec;68(12):e29397. doi: 10.1002/pbc.29397
   PubMed Web of Science ®Google Scholar
• Pierce CA, Sy S, Galen B, et al. Natural mucosal barriers and COVID-19 in children. JCI Insight. 2021 May 10;6(9):e148694. doi: 10.1172/jci.insight.148694
   PubMed Web of Science ®Google Scholar
• Tosato F, Bucciol G, Pantano G, et al. Lymphocytes subsets reference values in childhood. Cytometry. 2015 Jan;87(1):81–85. Epub 2014 Aug 6. doi: 10.1002/cyto.a.22520
   PubMedGoogle Scholar
• Zhang Q, Bastard P, Liu Z, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020 Oct 23;370(6515):eabd4570. Epub 2020 Sep 24. doi: 10.1126/science.abd4570
   PubMed Web of Science ®Google Scholar
• Khanmohammadi S, Rezaei N, Khazaei M, et al. A case of autosomal recessive interferon alpha/beta receptor alpha chain (IFNAR1) deficiency with severe COVID-19. J Clin Immunol. 2022;42:19–24. doi: 10.1007/s10875-021-01166-5
   PubMed Web of Science ®Google Scholar
• Asano T, Boisson B, Onodi F, et al. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. Sci Immunol. 2021 Aug 19;6(62):eabl4348. doi: 10.1126/sciimmunol.abl4348
   PubMed Web of Science ®Google Scholar
• Delmonte OM, Castagnoli R, Notarangelo LD. COVID-19 and inborn errors of immunity. Physiology. 2022 Nov 1;37(6):0. Epub 2022 Aug 9. doi: 10.1152/physiol.00016.2022
   PubMed Web of Science ®Google Scholar
• Meyts I, Bucciol G, Quinti I, et al. Coronavirus disease 2019 in patients with inborn errors of immunity: an international study. J Allergy Clin Immunol. 2021 Feb;147(2):520–531. Epub 2020 Sep 24. doi: 10.1016/j.jaci.2020.09.010.
   PubMed Web of Science ®Google Scholar
• Raja MA, Mendoza MA, Villavicencio A, et al. COVID-19 in solid organ transplant recipients: a systematic review and meta-analysis of current literature. Transplant Rev. 2021 Jan;35(1):100588. Epub 2020 Nov 14. doi: 10.1016/j.trre.2020.100588.
   Web of Science ®Google Scholar
• Avanzato VA, Matson MJ, Seifert SN, et al. Case study: Prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer. Cell. 2020 Dec 23;183(7):1901–1912.e9. Epub 2020 Nov 4. doi: 10.1016/j.cell.2020.10.049
   PubMed Web of Science ®Google Scholar
• Nakajima Y, Ogai A, Furukawa K, et al. Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient. Journal Of Infection And Chemotherapy. 2021 Feb;27(2):387–389. Epub 2020 Dec 4. doi: 10.1016/j.jiac.2020.12.001.
   PubMed Web of Science ®Google Scholar
• Madhusoodhan PP, Pierro J, Musante J, et al. Characterization of COVID-19 disease in pediatric oncology patients: the New York-New Jersey regional experience. Pediatric Blood Cancer. 2021 Mar;68(3):e28843. Epub 2020 Dec 18. doi: 10.1002/pbc.28843.
   PubMed Web of Science ®Google Scholar
• Millen GC, Arnold R, Cazier JB, et al. Severity of COVID-19 in children with cancer: Report from the United Kingdom paediatric coronavirus cancer monitoring project. Br J Canc. 2021 Feb;124(4):754–759. Epub 2020 Dec 10. doi: 10.1038/s41416-020-01181-0
   PubMed Web of Science ®Google Scholar
• Johnston EE, Martinez I, Davis ES, et al. SARS-CoV-2 in childhood cancer in 2020: a disease of disparities. J Clin Oncol. 2021 Dec 1;39(34):3778–3788. Epub 2021 Oct 25. doi: 10.1200/JCO.21.00702.
   PubMed Web of Science ®Google Scholar
• COVID-19 and Childhood Cancer Registry [Internet]. St. Jude Global. [cited 2021 Sep 14]. Available from: https://global.stjude.org/en-us/global-covid-19-observatory-and-resource-center-forchildhood-cancer/registry.Html
   Google Scholar
• Andre N, Rouger-Gaudichon J, Brethon B, et al. COVID-19 in pediatric oncology from French pediatric oncology and hematology centers: high risk of severe forms? Pediatr Blood Cancer. 2020 Epu;67(7):e28392. doi: 10.1002/pbc.28392.
   PubMed Web of Science ®Google Scholar
• Stokes CL, Patel PA, Sabnis HS, et al. Severe COVID-19 disease in two pediatric oncology patients. Pediatr Blood Cancer. 2020;67:e28432. Epub 2020 Jul 6. doi: 10.1002/pbc.28432.
   PubMed Web of Science ®Google Scholar
• Fonseca EV, Pardo CA, Linares A, et al. Clinical characteristics and outcomes of a cohort of pediatric oncohematologic patients with COVID-19 infection in the city of Bogotá, Colombia. Colombia Pediatr Infect Dis J. 2021;40(6):499–502. doi: 10.1097/INF.0000000000003135
   PubMed Web of Science ®Google Scholar
• Ronsley R, Bouffet E. COVID-19 in pediatric cancer: where are the brain tumors? Neuro Oncol. 2021 Nov 2;23(11):1977–1979. doi: 10.1093/neuonc/noab189
   PubMed Web of Science ®Google Scholar
• Dorantes‐Acosta E, Avila‐Montiel D, Klunder‐Klunder M, et al. Survival and complications in pediatric patients with cancer and COVID‐19: a meta‐analysis. Front Oncol. 2021;3103. eCollection 2020. doi: 10.3389/fonc.2020.608282
   Google Scholar
• El-Quhayri AE, Benmelouka AY, Dahy A, et al. COVID-19 outcomes in paediatric cancer: a large scale pooled meta-analysis of 984 cancer patients. Rev Med Virol. 2022 Sep;32(5):e2344. Epub 2022 Mar 5. doi: 10.1002/rmv.2344
   PubMed Web of Science ®Google Scholar
• Global Health Research Group on Children’s Non-Communicable Diseases Collaborative. Twelve-month observational study of children with cancer in 41 countries during the COVID-19 pandemic. BMJ Glob Health. 2022 Oct;7(10):e008797. doi: 10.1136/bmjgh-2022-008797
   PubMed Web of Science ®Google Scholar
• Oz-Alcalay L, Elitzur S, Amitai N, et al. COVID‑19 infection in pediatric patients treated for cancer. Int J Clin Oncol. 2022 Feb;27(2):448–454. Epub 2021 Nov 6. doi: 10.1007/s10147-021-02068-7
   PubMed Web of Science ®Google Scholar
• Schlage S, Lehrnbecher T, Berner R, et al. SARS-CoV-2 in pediatric cancer: a systematic review. Eur J Pediatr. 2022 Apr;181(4):1413–1427. Epub 2022 Jan 10. PMID: 35006377; PMCID: PMC8744033. doi: 10.1007/s00431-021-04338-y
   PubMed Web of Science ®Google Scholar
• Hrusak O, Kalina T, Wolf J, et al. Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment. Eur J Cancer [ Epub 2020 Apr 7]. 2020;132:11–16. doi: 10.1016/j.ejca.2020.03.021
   PubMed Web of Science ®Google Scholar
• Verbruggen LC, Wang Y, Armenian SH, et al. Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: a statement from the international late effects of childhood cancer guideline harmonization group. Pediatr Blood Cancer. 2020 Dec;67(12):e28702. Epub 2020 Sep 23. PMID: 32969160; PMCID: PMC7537044. doi: 10.1002/pbc.28702
   PubMed Web of Science ®Google Scholar
• Martin SD, Davis ES, Dai C, et al. Clinical features and risk factors associated with multisystem inflammatory syndrome in children with cancer and COVID-19. JAMA Oncol. 2023 May 11:e230525. PMID: 37166782. doi: 10.1001/jamaoncol.2023.0525
   Web of Science ®Google Scholar
• Dufort EM, Koumans EH, Chow EJ, et al.; New York State and Centers for Disease Control and Prevention Multisystem Inflammatory Syndrome in Children Investigation Team. Multisystem inflammatory syndrome in children in New York State. N Engl J Med. 2020;383(4):347–358. doi: 10.1056/NEJMoa2021756.
   PubMed Web of Science ®Google Scholar
• CDC/CSTE Standardized Case Definition for Surveillance of Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection. [cited 2023 Jan 27]; Available from: https://cdn.ymaws.com/www.cste.org/resource/resmgr/ps/ps2022/22-ID-02_MISC.pdf.
   Google Scholar
• World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID-19: scientific brief. 2020. [cited 2020 May 17]; Available from: https://www.who.int/publications-detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19.
   Google Scholar
• Wolfs TFW, Attarbaschi A, Balduzzi A, et al. COVID-19—impact on childhood haematology patients. Hemasphere. 2020;4:e465. eCollection 2020 Oct. doi: 10.1097/HS9.0000000000000465.
   PubMed Web of Science ®Google Scholar
• Hamdy R, El-Mahallawy H, Ebeid E. COVID-19 infection in febrile neutropenic pediatric hematology oncology patients. Pediatr Blood Cancer. 2021;68:e28765. Epub 2020 Oct 16. doi: 10.1002/pbc.28765
   PubMed Web of Science ®Google Scholar
• Gampel B, Troullioud Lucas AG, Broglie L, et al. COVID-19 disease in New York city pediatric hematology and oncology patients. Pediatr Blood Cancer. 2020;67:e28420. Epub 2020 Jun 26. doi: 10.1002/pbc.28420.
   PubMedGoogle Scholar
• Ebeid FSE, Ragab IA, Elsherif NHK, et al. COVID-19 in children with cancer: a single low-middle income center experience. J Pediatri Hematol Oncol. 2021 Nov 1;43(8):e1077–e1081. doi: 10.1097/MPH.0000000000002025
   PubMed Web of Science ®Google Scholar
• Boulad F, Kamboj M, Bouvier N, et al. COVID-19 in children with cancer in New York city. JAMA Oncol. 2020;6:145960. doi: 10.1001/jamaoncol.2020.2028
   Web of Science ®Google Scholar
• Balduzzi A, Brivio E, Rovelli A, et al. Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia. Italy Estote Parati Bone Marrow Transplant. 2020 Epu;55:1900–1905. doi: 10.1038/s41409-020-0895-4.
   PubMed Web of Science ®Google Scholar
• Mayanskiy N, Luchkina P, Fedorova N, et al. Seroconversion and dynamics of the anti-SARS-CoV-2 antibody response related to a hospital COVID-19 outbreak Among pediatric oncology patients. Leukemia. 2021;35(6):1820–1822. Epub 2021 May 18. doi: 10.1038/s41375-021-01288-0 .
   PubMed Web of Science ®Google Scholar
• Millen GC, Arnold R, Cazier J-B, et al. Severity of COVID-19 in children with cancer: Report from the United Kingdom paediatric coronavirus cancer monitoring projec. Br J Cancer. 2021;124:754–759. Epub 2020 Dec 10. doi: 10.1038/s41416-020-01181-0.
   PubMed Web of Science ®Google Scholar
• Müller J, Szűcs-Farkas D, Szegedi I, et al. Clinical course of COVID-19 disease in children treated with neoplastic diseases in Hungary. Pathol Oncol Res [ eCollection 2022]. 2022;28:1610261. doi: 10.3389/pore.2022.1610261
   PubMed Web of Science ®Google Scholar
• Wei M, Yuan J, Liu Y, et al. Novel coronavirus infection in hospitalized infants under 1 year of age in China. JAMA. 2020 Apr 7;323(13):1313–1314. doi: 10.1001/jama.2020.2131
   PubMed Web of Science ®Google Scholar
• Cai J, Xu J, Lin D, et al. A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clin Infect Dis. 2020 Sep 12;71(6):1547–1551. doi: 10.1093/cid/ciaa198
   PubMed Web of Science ®Google Scholar
• Liu W, Zhang Q, Chen J, et al. Detection of covid-19 in children in early January 2020 in Wuhan, China. N Engl J Med. 2020 Apr 2;382(14):1370–1371. Epub 2020 Mar 12. doi: 10.1056/NEJMc2003717
   PubMed Web of Science ®Google Scholar
• Parker RS, Le J, Doan A, et al. COVID-19 outcomes in children, adolescents and young adults with cancer. Int J Cancer. 2022 Dec 1;151(11):1913–1924. Epub 2022 Jul 19. doi: 10.1002/ijc.34202
   PubMed Web of Science ®Google Scholar
• GBD 2017 Childhood Cancer Collaborators. The global burden of childhood and adolescent cancer in 2017: an analysis of the global burden of disease study 2017. Lancet Oncol. 2019;20:1211–1225. doi: 10.1016/S1470-2045(19)30339-0
   PubMed Web of Science ®Google Scholar
• Kala KY, Kim TO, Doherty EE, et al. COVID-19 outcomes in a large pediatric hematology-oncology center in Houston, Texas. Pediatr Hematol Oncol. 2021 Nov;38(8):695–706. Epub 2021 May 25. doi: 10.1080/08880018.2021.1924327
   PubMed Web of Science ®Google Scholar
• Guilcher GMT, Rivard L, Huang JT, et al. Immune function in childhood cancer survivors: a children’s oncology group review. Lancet Child Adolesc Health. 2021 Apr;5(4):284–294. Epub 2021 Feb 16. doi: 10.1016/S2352-4642(20)30312-6
   PubMedGoogle Scholar
• Russel B, Moss C, George G, et al. Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence. Ecancermedicalscience. 2020;14:1022. Published online 2020 Mar 27. doi: 10.3332/ecancer.2020.1022.
   PubMed Web of Science ®Google Scholar
• Parambil BC, Moulik NR, Dhamne C, et al. COVID‑19 in children with cancer and continuation of cancer‑directed therapy during the infection. Indian J Pediatr. 2022 May;89(5):445–451. Epub 2021 Aug 11. doi: 10.1007/s12098-021-03894-3.
   PubMed Web of Science ®Google Scholar
• Mukkada S, Bhakta N, Chantada GL, et al. Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study. Lancet Oncol. 2021;22(10):1416–1426. Epub 2021 Aug 26. doi: 10.1016/S1470-2045(21)00454-X.
   PubMed Web of Science ®Google Scholar
• Tepasse PR, Hafezi W, Lutz M, et al. Persisting SARS-CoV-2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature. Br J Haematol. 2020;190(2):185–188. Epub 2020 Jun 22. doi: 10.1111/bjh.16896 .
   PubMed Web of Science ®Google Scholar
• Yasuda H, Tsukune Y, Watanabe N, et al. Persistent COVID-19 pneumonia and failure to develop anti-SARS-CoV-2 antibodies during rituximab maintenance therapy for follicular lymphom. Clin Lymphoma Myeloma Leuk. 2020;20(11):774–776. Epub 2020 Aug 22. doi: 10.1016/j.clml.2020.08.017.
   PubMed Web of Science ®Google Scholar
• Koff AG, Laurent-Rolle M, Hsu JC, et al. Prolonged incubation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a patient on rituximab therapy. Infect Control Hosp Epidemiol. 2021 Oct;42(10):1286–1288. Epub 2020 Oct 7. doi: 10.1017/ice.2020.1239
   PubMed Web of Science ®Google Scholar
• Chappell L, Horby P, Lim WS, et al.; RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with covid-19. N Engl J Med. 2021 Feb 25;384(8):693–704. Epub 2020 Jul 17. doi: 10.1056/NEJMoa2021436
   PubMed Web of Science ®Google Scholar
• Flisiak R, Parczewski M, Horban A, et al. Management of SARS-CoV-2 infection: recommendations of the polish association of epidemiologists and infectivologists. Annex no. 2 as of October 13, 2020. Pol Arch Intern Med. 2020 Jun 25;130(6):557–558. Epub 2020 Jun 8. doi: 10.20452/pamw.15658
   PubMedGoogle Scholar
• Hammond J, Leister-Tebbe H, Gardner A, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with covid-19. N Engl J Med. 2022;386(15):1397–1408. Epub 2022 Feb 16. doi: 10.1056/NEJMoa2118542 .
   PubMed Web of Science ®Google Scholar
• Gottlieb RL, Vaca CE, Paredes R, et al. Early remdesivir to prevent progression to severe covid-19 in outpatients. N Engl J Med. 2022 Epu;386(4):305–315. doi: 10.1056/NEJMoa2116846
   PubMed Web of Science ®Google Scholar
• Navarro DF, Tendal B, Tingay D, et al. Clinical care of children and adolescents with COVID-19: recommendations from the national COVID-19 clinical evidence taskforce. Med J Aust. 2022;216:255–263. Epub 2021 Oct 24. doi: 10.5694/mja2.51305.
   PubMedGoogle Scholar
• Crighton GL, Greenway A. Russell S. Clinical care of children and adolescents with COVID-19: recommendations from the national COVID-19 clinical evidence taskforce. Med J Aust. 2022;216(9):488. Epub 2022 Apr 21. doi: 10.5694/mja2.51511
   PubMedGoogle Scholar
• Liu E, Smyth RL, Li Q, et al. Guidelines for the prevention and management of children and adolescents with COVID19. Eur J Pediatr. 2022 Epu;181(12):4019–4037. doi: 10.1007/s00431-022-04615-4
   PubMed Web of Science ®Google Scholar
• Choi S-H, Choi JH, Yun KW. Therapeutics for the treatment of coronavirus disease 2019 in children and adolescents. Clin Exp Pediatr. 2022;65(8):377–386. Epub 2022 Jun 27. doi: 10.3345/cep.2022.00458
   PubMedGoogle Scholar
• Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. [cited 2023 Jan 22]; Ava: https://www.covid19treatmentguidelines.nih.gov/(downloaded.
   Google Scholar
• El Chaer F, Auletta JJ, Chemaly RF. How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies. Blood. 2022;140(7):673–684. doi: 10.1182/blood.2022016089
   PubMed Web of Science ®Google Scholar
• Cesaro S, Ljungman P, Mikulska M, et al. Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European conference on infections in leukaemia (ECIL 9). Leukemia. 2022 Jun;36(6):1467–1480. Epub 2022 Apr 29. doi: 10.1038/s41375-022-01578-1
   PubMed Web of Science ®Google Scholar
• Dioverti V, Boghdadly ZE, Shahid Z, et al. Revised guidelines for coronavirus disease 19 management in hematopoietic cell transplantation and cellular therapy recipients (August 2022). Transplant Cell Ther. 2022 Dec;28(12):810–821. Epub 2022 Sep 11. doi: 10.1016/j.jtct.2022.09.002
   PubMedGoogle Scholar
• Takashita E, Yamayoshi S, Simon V, et al. Efficacy of antibodies and antiviral drugs against Omicron BA.2.12.1, BA.4, and BA.5 subvariants. N Engl J Med. 2022;387(5):468–470. Epub 2022 Jul 20. doi: 10.1056/NEJMc2207519 .
   PubMed Web of Science ®Google Scholar
• Goldman DL, Aldrich ML, Hagmann SHF, et al. Compassionate use of remdesivir in children with severe COVID-19. Pediatrics. 2021;147(5):e2020047803. doi: 10.1542/peds.2020-047803
   PubMed Web of Science ®Google Scholar
• Méndez-Echevarría A, Pérez-Martínez A, Gonzalez Del Valle L, et al. Compassionate use of remdesivir in children with COVID-19. Eur J Pediatr. 2021;180(4):1317–1322. Epub 2020 Nov 16. doi: 10.1007/s00431-020-03876-1
   PubMed Web of Science ®Google Scholar
• Manabe S, Mizuno S, Jinda T, et al. Safety of remdesivir in 20 children with COVID-19: case series. Biol Pharm Bull. 2022;45:1853–1856. Epub 2022 Oct 8. doi: 10.1248/bpb.b22-00470.
   PubMed Web of Science ®Google Scholar
• Esposito S, Autore G, Argentiero A, et al. Update on COVID-19 therapy in pediatric age. Pharmaceuticals. 2022;15(12):1512. doi: 10.3390/ph15121512
   Web of Science ®Google Scholar
• Bose-Brill S, Hirabayashi K, Pajor NM, et al. Pediatric nirmatrelvir/ritonavir prescribing patterns during the COVID-19 pandemic. MedRxiv. 2022. doi: 10.1101/2022.12.23.22283868
   PubMedGoogle Scholar
• Yan G, Zhou J, Zhu H, et al. The feasibility, safety, and efficacy of paxlovid treatment in SARS-CoV-2-infected children aged 6–14 years: a cohort study. Ann Transl Med. 2022;10:619. doi: 10.21037/atm-22-2791
   PubMed Web of Science ®Google Scholar
• Mak G, Dassner AM, Hammer BM, et al. Safety and tolerability of monoclonal antibody therapies for treatment of COVID-19 in pediatric patients. Pediatr Infect Dis J. 2021;40(12):e507–e509. doi: 10.1097/INF.0000000000003263
   PubMed Web of Science ®Google Scholar
• Bhatt NS, Sharma A, Martin A, et al. Clinical characteristics and outcomes of COVID-19 in pediatric and early adolescent and young adult hematopoietic stem cell transplant recipients: a cohort study. Transplant Cell Ther. 2022;28(10):.e696.1–.e696.7. Epub 2022 Jul 4. doi: 10.1016/j.jtct.2022.06.026 .
   Google Scholar
• Offenbacher R, Gorlick J, Weiser DA. Omicron variant of SARS-CoV-2, an epidemiologic assessment of pediatric oncology patients in the bronx. Cancer Rep. 2022;5(11):e1724. doi: 10.1002/cnr2.1724
   Google Scholar
• European Medicine Agency. COVID-19 vaccines: authorised Published 2022. [cited 2022 Aug 2]; Available from: https://www.ema.europa.eu/en/humanregulatory/overview/public-health-threats/coronavirus-diseasecovid-19/treatments-vaccines/vaccines-covid-19/covid-19-vaccines-authorised#authorised-covid-19 vaccines-section.
   Google Scholar
• Ali K, Berman G, Zhou H, et al. Evaluation of mRNA-1273 SARS-CoV-2 vaccine in adolescents. N Engl J Med. 2021;385(24):2241–2251. Epub 2021 Aug 11. doi: 10.1056/NEJMoa2109522
   PubMed Web of Science ®Google Scholar
• Simões EAF, Klein NP, Sabharwal C, et al. Immunogenicity and safety of a third COVID-19 BNT162b2 mRNA vaccine dose in 5- to 11-year olds. J Pediatric Infect Dis Soc. 2023;12(4):234–238. doi: 10.1093/jpids/piad015
   PubMedGoogle Scholar
• Hu M, Wong HL, Feng Y, et al. Safety of the BNT162b2 COVID-19 vaccine in children aged 5 to 17 years. JAMA Pediatr. 2023;177(7):710–717. doi: 10.1001/jamapediatrics.2023.1440
   PubMed Web of Science ®Google Scholar
• Áñez G, Dunkle LM, Gay CL, et al. Safety, immunogenicity, and efficacy of the NVX-CoV2373 COVID-19 vaccine in adolescents. A randomized clinical trial. JAMA Netw Open. 2023;6(4):e239135. doi: 10.1001/jamanetworkopen.2023.9135
   PubMed Web of Science ®Google Scholar
• Sadeghi S, Kalantari Y, Shokri S, et al. Immunologic response, efficacy, and safety of vaccines against COVID-19 infection in healthy and immunosuppressed children and adolescents aged 2-21 years old: a systematic review and meta-analysis. J Clin Virol. 2022;153:105196. doi: 10.1016/j.jcv.2022.105196
   PubMed Web of Science ®Google Scholar
• National Institutes of Health. Coronavirus disease 2019 (COVID-19) treatment guidelines. [ Updated 2022 Aug 8: cited 2022 Aug 14]; Ava: https://www.covid19treatmentguidelines.nih.gov/.
   Google Scholar
• Corti C, Antonarelli G, Scotte F, et al. Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review. Annals Of Oncology. 2021;33(2):158–168. Epub 2021 Oct 28. doi: 10.1016/j.annonc.2021.10.014
   PubMed Web of Science ®Google Scholar
• Ljungman P. Vaccination of immunocompromised patients. Clin Microbiol Infect. 2012;18(Suppl 5):93–99. doi: 10.1111/j.1469-0691.2012.03971.x
   PubMedGoogle Scholar
• Caniza MA, Homsi MR, Bate J, et al. Answers to common questions about COVID-19 vaccines in children with cancer. Pediatr Blood Cancer. 2022 Dec;69(12):e29985. Epub 2022 Sep 16. PMID: 36114651; PMCID: PMC9538403. doi: 10.1002/pbc.29985
   PubMed Web of Science ®Google Scholar
• Thakkar A, Gonzalez-Lugo JD, Goradia N, et al. Seroconversion rates following COVID-19 vaccination among patients with cancer. Cancer Cell. 2021 Epu;39(8):1081–1090.e1082. doi: 10.1016/j.ccell.2021.06.002.
   PubMed Web of Science ®Google Scholar
• Cesaro S, Muggeo P, Zama D, et al. Consensus on COVID-19 vaccination in pediatric oncohematological patients, on behalf of infectious working group of Italian association of pediatric hematology oncology. J Clin Med. 2022 Feb 24;11(5):1235. PMID: 35268326; PMCID: PMC8911119. doi: 10.3390/jcm11051235.
   PubMed Web of Science ®Google Scholar
• Cordonnier C, Einarsdottir S, Cesaro S, et al. Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European conference on infections in leukaemia (ECIL 7). Lancet Infect Dis. 2019;19:e200–e212. Epub 2019 Feb 8. doi: 10.1016/S1473-3099(18)30600-5.
   PubMed Web of Science ®Google Scholar
• AIFA. http://Available onlinehttps://www.aifa.gov.it/documents/20142/1567238Lista_AIFA_Immunosoppressori_Dose_Additionale.pdf(accessed on 2 January 2022). And COVID-19 vaccines for moderately or severely immunocompromised people. [cited 2022 Jan 2]; Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html.
   Google Scholar
• Witberg G, Barda N, Hoss S, et al. Myocarditis after covid-19 vaccination in a large Health care organization. N Engl J Med. 2021;385:2132–2139. Epub 2021 Oct 6. doi: 10.1056/NEJMoa2110737.
   PubMed Web of Science ®Google Scholar
• Majeed A, Wright T, Guo B, et al. The global impact of COVID-19 on childhood cancer outcomes and care delivery - a systematic review. Front Oncol. 2022 Apr 7;12:869752. eCollection 2022. doi: 10.3389/fonc.2022.869752.
   PubMed Web of Science ®Google Scholar
• Makris K, Spanou L. Acute kidney injury: definition, pathophysiology and clinical phenotypes. Clin Biochem Rev. 2016;37:85–98.
   PubMedGoogle Scholar
• Georgiadis G, Zisis J-E, Docea AO, et al. Current concepts on the reno-protective effects of phosphodiesterase 5 inhibitors in acute injury: systematic search and review. Kidney J Clin Med. 2020;9(5):1284. doi: 10.3390/jcm9051284
   PubMed Web of Science ®Google Scholar
• Mansour SG, Zhang WR, Moledina DG, et al. The association of angiogenesis markers with acute kidney injury and mortality after cardiac surgery. American Journal Of Kidney Diseases. 2019;74(1):36–46. Epub 2019 Apr 5. doi: 10.1053/j.ajkd.2019.01.028
   PubMed Web of Science ®Google Scholar
• Rossaint J, Zarbock A. Acute kidney injury: definition, diagnosis and epidemiology. Minerva Urol Nefrol. 2016 Feb;68(1):49–57.
   PubMed Web of Science ®Google Scholar
• Vijayan A. Tackling AKI: prevention, timing of dialysis and follow-up. Nat Rev Nephrol. 2021 Feb;17(2):87–88. doi: 10.1038/s41581-020-00390-3
   PubMed Web of Science ®Google Scholar
• Widemann BC, Balis FM, Kempf-Bielack B, et al. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma. Cancer. 2004;100(10):2222–2232. doi: 10.1002/cncr.20255
   PubMed Web of Science ®Google Scholar
• Nicastro E, Verdoni L, Bettini LR, et al. COVID-19 in immunosuppressed children. Front Pediatr. 2021 Apr 29;9:629240. doi: 10.3389/fped.2021.629240
   PubMedGoogle Scholar
• Tay MZ, Poh CM, Rénia L, et al. The trinity of COVID-19: immunity, inflammation and intervention. Rev Immunol. 2020 Jun;20(6):363–374. Epub 2020 Apr 28. doi: 10.1038/s41577-020-0311-8
   Google Scholar